The Planaccording to the statement above the company is launching products in legal jurisdictions.....along with a couple of handfuls of other companies competing for the same space....Oregon Holland Brazil.....
the market is limited right now and the competition is lively...future markets are unknown
as far as studies go on the efficacy of benefits of psilocybin we have a study in early 2021 with results likely by June 2021.....other companies are also doing studies to prove benefits for depression and anxiety and such....but studies don't make money and profit...sales do
our competative edge is strip application although Revive has a similar strip application....we are all cashed up with 45 million
the big question.....how do we excel in a overcroweded space with limited current market and really nothing proprietary......I think that explains the big out of shares at 70 cents....time will tell